Human medicines European public assessment report (EPAR): Pregabalin Zentiva, pregabalin, Date of authorisation: 17/07/2015, Revision: 18, Status: Authorised

Shoulder prostheses - Notified body 0459 - 25/08/2022 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)

Medical device expert panels

Class III implantable devices and Class IIb medical devices intended to administer or remove medicinal products: expert panel opinions

Class D in vitro diagnostic devices: expert panel views

Human medicines European public assessment report (EPAR): Aldurazyme, laronidase, Date of authorisation: 09/06/2003, Revision: 27, Status: Authorised

Determination of IgM antibodies to SARS-CoV-2 - Notified body 0123 - 03/02/2022 - View in the context of the performance evaluation consultation procedure (PECP)

Minutes of the COMP meeting 10-12 September 2024

PSUSA/00001512/202403

Submission of Manufacturers and Manufacturing Operations to Product Management Service (PMS), Online, European Medicines Agency, Amsterdam, the Netherlands, from 25 November 2024, 10:00 (CET) to 25 November 2024, 11:30 (CET)